Clinical Trial Co. Owner Admits Lying To FDA
The co-owner of a Miami clinical trial company pled guilty on Wednesday to lying to federal regulators investigating an alleged scheme to falsify research records and score contracts with drug developers....To view the full article, register now.
Already a subscriber? Click here to view full article